Sanofi Won't Go Above $70 per Share for Genzyme

26.08.2010 - Sanofi-Aventis is not willing to pay more than $70 per share for U.S. biotech Genzyme and may look at alternative targets, Bloomberg reported on Wednesday, citing sources familiar...